New strategies for using mucosal vaccination to achieve more effective immunization.
about
The development of an AIDS mucosal vaccine.Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens.Current status of a mucosal vaccine against dental caries.Antipeptide antibody responses following intranasal immunization: effectiveness of mucosal adjuvants.Intranasal antibody prophylaxis for protection against viral disease.Exploring novel vaccines against Helicobacter pylori: protective and therapeutic immunization.Levels of expression and immunogenicity of attenuated Salmonella enterica serovar typhimurium strains expressing Escherichia coli mutant heat-labile enterotoxinIntranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects.Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.Immunization against natural Helicobacter pylori infection in nonhuman primates.The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice.Establishment and Evaluation of an in vitro M Cell Model using C2BBe1 Cells and Raji Cells.Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission.Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.Effects of the nature of adjuvant and site of parenteral immunization on the serum and mucosal immune responses induced by a nasal boost with a vaccine alone.Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccineMutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance.Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae.Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxicationNasal immunization with homogenate and peptide antigens induces protective immunity against Trichinella spiralisVaccine adjuvants: current state and future trends.Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunityIntranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A.Mucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection.Feasibility of aerosol vaccination in humans.Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice.Immunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice.Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvantSalivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice.Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines.In vivo distribution of surface-modified PLGA nanoparticles following intravaginal deliveryBacterial spores as heat stable vaccine vehicles.Protective role of purified cysteine proteinases against Fasciola gigantica infection in experimental animals.Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective
P2860
Q30408103-F961B58F-2B63-442D-B1C0-C9EEEF13AB42Q33552360-259F484E-4A37-41F9-A2D5-5864874C4710Q33592225-25CB625F-E3BF-47BE-972D-E092EFADD658Q33594600-70768924-3335-44B4-918A-FBAD0FB25E4FQ33597488-FCD7E0E2-A4ED-4D3F-A33F-4F15DAE2A1DAQ33683058-1D7BAA95-48AF-4A80-9624-F591635F319CQ33727845-6E43DA96-C82F-4C55-B140-5B07257BC8F8Q33748369-FEEA6B70-9297-4B44-84C6-DAE8C7924453Q33752052-B8A15495-D019-4A00-A470-F3207FED7AD8Q33754743-7DACDF87-DC41-4EF3-A458-9C949170635BQ33760450-36FFAF65-EB8E-434D-BF41-446107C76081Q33762386-08913951-E3AA-44D7-9FD5-D5AF25E97B62Q33877406-D83FC50D-39B8-4E56-A959-0591BB252DECQ33920529-CF0A1E88-FD92-41CF-A3D0-FB93B78C04F8Q33925615-005E7FC4-2CD8-4F43-9936-D8517A963E8EQ33990842-AA2066D9-16E8-457E-8F2C-59A3E9E03196Q33997478-6131B7C9-9F90-4A05-8664-8D744B8BAFEFQ34000420-AD7C80EA-01A7-45F5-8DA5-C706B2D8D15EQ34002672-BD9C79D8-1C12-4DFA-BE7F-0AF07E4B04B9Q34008642-F6C91984-6DF9-4F9C-A84F-5E25D9B7F454Q34009439-0C1D0AB6-DE74-4A9D-90A2-4F939246A525Q34012394-350A4529-9F46-4D02-99E2-F3DDA7C8BD2DQ34258467-39326B4C-87A5-4122-BC6F-068C0448A18BQ34358206-8613A32D-B936-4E0C-9D0C-477237638D44Q34415303-27E5B9ED-CE7B-42CA-A1D3-EFB2C83B3DA6Q34492667-994F833A-3223-4F91-88CF-9148A80844D1Q34518201-EB7EE6F5-BC71-48C8-B6BB-71F1F3716726Q35005641-73533494-5E7B-48BC-A98B-3EB6B936D77CQ35091812-942D379E-44BC-4236-8256-25EDD951A47BQ35123457-522B620F-C18A-4499-A88C-895002298ADCQ35440298-2484D620-5675-4948-86EF-F1CB8818D8DFQ35467763-FB5940E1-CFF4-4FF5-8073-752391F5D9E3Q35476128-57D3C148-F442-4510-AF4F-83649DEF98E2Q35482140-F067E8E8-67A8-44B9-BA58-1CAE7914F4F1Q35490149-0C68418A-DC70-408A-BC29-BBC6192E1B58Q35529377-4BB9999C-48A6-4D9B-9F48-F828327E3B45Q35563449-4BA1D1CF-6C52-40C0-A4C6-4EC9A0BCEEDFQ35594081-A2FC0D5B-0E20-481F-9F7A-75DCA0D2C705Q35842682-DC1872F8-CED8-4313-AE18-E78CE839ED86Q35844791-9FDF1AF4-ACBB-46DA-A8B6-9F36F10C3BBE
P2860
New strategies for using mucosal vaccination to achieve more effective immunization.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
New strategies for using mucosal vaccination to achieve more effective immunization.
@en
type
label
New strategies for using mucosal vaccination to achieve more effective immunization.
@en
prefLabel
New strategies for using mucosal vaccination to achieve more effective immunization.
@en
P1433
P1476
New strategies for using mucosal vaccination to achieve more effective immunization.
@en
P2093
P304
P356
10.1016/0264-410X(94)90112-0
P407
P577
1994-04-01T00:00:00Z